Concepts (91)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neurology | 4 | 2022 | 44 | 1.570 |
Why?
|
| Quality Improvement | 5 | 2022 | 464 | 1.190 |
Why?
|
| Polyneuropathies | 2 | 2022 | 13 | 1.160 |
Why?
|
| Nervous System Diseases | 2 | 2020 | 108 | 1.070 |
Why?
|
| Neurotology | 2 | 2018 | 4 | 0.710 |
Why?
|
| Deglutition Disorders | 1 | 2021 | 43 | 0.670 |
Why?
|
| Nerve Compression Syndromes | 1 | 2019 | 12 | 0.610 |
Why?
|
| Sciatic Nerve | 1 | 2019 | 30 | 0.600 |
Why?
|
| Iliac Vein | 1 | 2019 | 10 | 0.600 |
Why?
|
| Medication Reconciliation | 1 | 2019 | 14 | 0.590 |
Why?
|
| Ear Diseases | 1 | 2018 | 5 | 0.570 |
Why?
|
| Vestibular Diseases | 1 | 2018 | 6 | 0.570 |
Why?
|
| Brain Diseases | 2 | 2010 | 76 | 0.560 |
Why?
|
| Medication Errors | 1 | 2019 | 110 | 0.550 |
Why?
|
| Brain Ischemia | 1 | 2021 | 418 | 0.520 |
Why?
|
| Myasthenia Gravis | 1 | 2016 | 12 | 0.500 |
Why?
|
| Diet, Gluten-Free | 1 | 2015 | 6 | 0.460 |
Why?
|
| Thiamine Deficiency | 1 | 2015 | 8 | 0.450 |
Why?
|
| Sensory Receptor Cells | 1 | 2015 | 21 | 0.450 |
Why?
|
| Stroke | 2 | 2021 | 1211 | 0.430 |
Why?
|
| Vertigo | 1 | 2012 | 7 | 0.380 |
Why?
|
| Registries | 1 | 2016 | 925 | 0.370 |
Why?
|
| Diabetic Neuropathies | 1 | 2012 | 7 | 0.360 |
Why?
|
| Analgesics | 1 | 2012 | 102 | 0.340 |
Why?
|
| Practice Guidelines as Topic | 2 | 2012 | 736 | 0.330 |
Why?
|
| Popliteal Vein | 1 | 2010 | 2 | 0.310 |
Why?
|
| Eye Abnormalities | 1 | 2010 | 21 | 0.310 |
Why?
|
| Mononeuropathies | 1 | 2010 | 5 | 0.310 |
Why?
|
| Muscular Diseases | 1 | 2010 | 50 | 0.310 |
Why?
|
| Aneurysm | 1 | 2010 | 58 | 0.300 |
Why?
|
| Calcinosis | 1 | 2009 | 84 | 0.280 |
Why?
|
| Humans | 17 | 2022 | 65142 | 0.280 |
Why?
|
| Neural Conduction | 2 | 2015 | 32 | 0.190 |
Why?
|
| Electrodiagnosis | 2 | 2015 | 20 | 0.190 |
Why?
|
| Postoperative Complications | 1 | 2010 | 1322 | 0.180 |
Why?
|
| Hospitals, Community | 1 | 2021 | 71 | 0.170 |
Why?
|
| Arthritis, Juvenile | 1 | 2020 | 7 | 0.160 |
Why?
|
| Posterior Leukoencephalopathy Syndrome | 1 | 2020 | 13 | 0.160 |
Why?
|
| Vestibular Neuronitis | 1 | 2018 | 1 | 0.140 |
Why?
|
| Female | 7 | 2018 | 34031 | 0.140 |
Why?
|
| Health Resources | 1 | 2019 | 92 | 0.140 |
Why?
|
| Pyridostigmine Bromide | 1 | 2016 | 5 | 0.130 |
Why?
|
| Middle Aged | 5 | 2019 | 18273 | 0.130 |
Why?
|
| Stroke Rehabilitation | 1 | 2017 | 51 | 0.130 |
Why?
|
| Quality Indicators, Health Care | 1 | 2020 | 346 | 0.120 |
Why?
|
| Neuromuscular Diseases | 1 | 2016 | 24 | 0.120 |
Why?
|
| Physician-Patient Relations | 1 | 2020 | 427 | 0.120 |
Why?
|
| Cholinesterase Inhibitors | 1 | 2016 | 50 | 0.120 |
Why?
|
| Societies, Medical | 1 | 2018 | 400 | 0.120 |
Why?
|
| Mass Screening | 1 | 2021 | 698 | 0.120 |
Why?
|
| Patient Safety | 1 | 2018 | 259 | 0.110 |
Why?
|
| Male | 4 | 2019 | 31056 | 0.100 |
Why?
|
| Benign Paroxysmal Positional Vertigo | 1 | 2012 | 2 | 0.100 |
Why?
|
| Quality of Life | 1 | 2020 | 1259 | 0.090 |
Why?
|
| Pregabalin | 1 | 2012 | 4 | 0.090 |
Why?
|
| Amitriptyline | 1 | 2012 | 7 | 0.090 |
Why?
|
| Physical Examination | 1 | 2012 | 109 | 0.090 |
Why?
|
| Clinical Coding | 1 | 2012 | 46 | 0.090 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2012 | 75 | 0.090 |
Why?
|
| Risk Assessment | 1 | 2018 | 2102 | 0.090 |
Why?
|
| Dystroglycans | 1 | 2010 | 4 | 0.080 |
Why?
|
| Spastic Paraplegia, Hereditary | 1 | 2009 | 13 | 0.080 |
Why?
|
| GTP Phosphohydrolases | 1 | 2009 | 64 | 0.070 |
Why?
|
| Movement Disorders | 1 | 2009 | 26 | 0.070 |
Why?
|
| Adenosine Triphosphatases | 1 | 2009 | 256 | 0.070 |
Why?
|
| Treatment Outcome | 1 | 2018 | 5791 | 0.070 |
Why?
|
| Adult | 3 | 2015 | 17359 | 0.060 |
Why?
|
| Bipolar Disorder | 1 | 2009 | 249 | 0.060 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2009 | 730 | 0.060 |
Why?
|
| Infant | 1 | 2010 | 1693 | 0.050 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2009 | 1656 | 0.040 |
Why?
|
| Mutation | 1 | 2009 | 2661 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2010 | 2244 | 0.040 |
Why?
|
| Aged | 1 | 2016 | 14963 | 0.040 |
Why?
|
| Betacoronavirus | 1 | 2020 | 180 | 0.030 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2020 | 250 | 0.030 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 205 | 0.030 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 219 | 0.030 |
Why?
|
| Pandemics | 1 | 2020 | 675 | 0.030 |
Why?
|
| Anterior Horn Cells | 1 | 2009 | 6 | 0.020 |
Why?
|
| Spastin | 1 | 2009 | 6 | 0.020 |
Why?
|
| Motor Neuron Disease | 1 | 2009 | 28 | 0.020 |
Why?
|
| Muscle Weakness | 1 | 2009 | 33 | 0.020 |
Why?
|
| Syndrome | 1 | 2009 | 180 | 0.020 |
Why?
|
| GTP-Binding Proteins | 1 | 2009 | 94 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2009 | 198 | 0.020 |
Why?
|
| Genotype | 1 | 2009 | 673 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2009 | 991 | 0.020 |
Why?
|
| Disease Progression | 1 | 2009 | 1219 | 0.010 |
Why?
|
| Muscle, Skeletal | 1 | 2009 | 787 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2009 | 918 | 0.010 |
Why?
|